Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
Launched by M.D. ANDERSON CANCER CENTER · Jul 20, 2021
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to close the surgical incision after liver tumor surgery. The goal is to find out whether using a short stitch technique is better than the traditional suture method for preventing incisional hernias, which are painful bulges that can occur at the surgery site. By comparing these two techniques, researchers hope to learn which one can help patients avoid this complication.
To participate in the trial, patients must be at least 18 years old and scheduled for liver surgery to remove a tumor. They should have a diagnosis of a malignant liver condition, and the surgery must involve a specific type of incision. However, individuals with a history of abdominal hernias or previous surgeries using mesh are not eligible. If you join the study, you can expect to receive either the short stitch or traditional suture technique during your surgery, and your recovery will be monitored to see how well you heal. This trial is currently looking for participants until November 2024.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing hepatectomy for malignant diagnosis (primary or secondary) from 5/1/2021 through 11/1/2024 will be eligible for inclusion in this study
- • Elective surgery
- • Age \>= 18
- • Planned midline laparotomy incision or inverted-L incision
- Exclusion Criteria:
- • Pre-existing abdominal hernia
- • History of mesh placement at prior laparotomy
- • Pregnant women
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Timothy E Newhook, MD
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials